Sangamo Therapeutics Newsroom

Sangamo Therapeutics Is Maintained at Overweight by Barclays

Dow JonesNov 14 22:24

TD Cowen Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating

Futu NewsNov 14 21:31

H.C. Wainwright Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 14 21:31

A Quick Look at Today's Ratings for Sangamo Therapeutics(SGMO.US), With a Forecast Between $3 to $10

Futu NewsNov 14 21:06

Wells Fargo Gives a Hold Rating to Sangamo Biosciences (SGMO)

TipRanksNov 14 17:54

Sangamo Therapeutics Analyst Ratings

BenzingaNov 5 21:24

H.C. Wainwright Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Raises Target Price to $10

Futu NewsNov 5 19:37

Truist Financial Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating

Futu NewsOct 24 18:41

TD Cowen Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating

Futu NewsOct 24 13:32

A Quick Look at Today's Ratings for Sangamo Therapeutics(SGMO.US), With a Forecast Between $1 to $5

Futu NewsOct 23 21:09

HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $5 Price Target

BenzingaOct 23 00:27

Sangamo Therapeutics Analyst Ratings

BenzingaOct 23 00:27

Sangamo Therapeutics Analyst Ratings

BenzingaAug 22 21:06

HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $5 Price Target

BenzingaAug 22 21:05

H.C. Wainwright Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Maintains Target Price $5

Futu NewsAug 22 18:33

RBC Capital Remains a Hold on Sangamo Biosciences (SGMO)

TipRanksAug 7 19:26

Sangamo Therapeutics Analyst Ratings

BenzingaJul 31 20:23

H.C. Wainwright Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Maintains Target Price $5

Futu NewsJul 31 18:33

HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $5 Price Target

BenzingaJul 25 03:23

Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know

BenzingaMay 15 23:05